Patents by Inventor Mark Shults

Mark Shults has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050245795
    Abstract: Abstract of the Disclosure An implantable analyte sensor including a sensing region for measuring the analyte and a non-sensing region for immobilizing the sensor body in the host. The sensor is implanted in a precisely dimensioned pocket to stabilize the analyte sensor in vivo and enable measurement of the concentration of the analyte in the host before and after formation of a foreign body capsule around the sensor. The sensor further provides a transmitter for RF transmission through the sensor body, electronic circuitry, and a power source optimized for long-term use in the miniaturized sensor body.
    Type: Application
    Filed: May 3, 2004
    Publication date: November 3, 2005
    Applicant: DexCom, Inc.
    Inventors: Paul Goode, Arnold Holmquist, Mark Tapsak, Mark Shults, Victoria Carr-Brendel, James Brauker, Paul Neale, Jason McClure, Mark Brister, Peter Simpson, Rathbun Rhodes
  • Publication number: 20050177036
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Application
    Filed: December 22, 2004
    Publication date: August 11, 2005
    Inventors: Mark Shults, Stuart Updike, Rathbun Rhodes
  • Publication number: 20050124873
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that slows accurate date to be obtained over long periods of time.
    Type: Application
    Filed: January 19, 2005
    Publication date: June 9, 2005
    Inventors: Mark Shults, Stuart Updike, Rathbun Rhodes, Barbara Gilligan, Mark Tapsak
  • Publication number: 20050103625
    Abstract: The present invention provides a sensor head for use in an implantable device that measures the concentration of an analyte in a biological fluid which includes: a non-conductive body; a working electrode, a reference electrode and a counter electrode, wherein the electrodes pass through the non-conductive body forming an electrochemically reactive surface at one location on the body and forming an electronic connection at another location on the body, further wherein the electrochemically reactive surface of the counter electrode is greater than the surface area of the working electrode; and a multi-region membrane affixed to the nonconductive body and covering the working electrode, reference electrode and counter electrode. In addition, the present invention provides an implantable device including at least one of the sensor heads of the invention and methods of monitoring glucose levels in a host utilizing the implantable device of the invention.
    Type: Application
    Filed: December 22, 2004
    Publication date: May 19, 2005
    Inventors: Rathbun Rhodes, Mark Tapsak, James Brauker, Mark Shults
  • Publication number: 20050031689
    Abstract: A biointerface membrane for an implantable device including a nonresorbable solid portion with a plurality of interconnected cavities therein adapted to support tissue ingrowth in vivo, and a bioactive agent incorporated into the biointerface membrane and adapted to modify the tissue response is provided. The bioactive agents can be chosen to induce vascularization and/or prevent barrier cell layer formation in vivo, and are advantageous when used with implantable devices wherein solutes are transported across the device-tissue interface.
    Type: Application
    Filed: May 10, 2004
    Publication date: February 10, 2005
    Applicant: DexCom, Inc.
    Inventors: Mark Shults, James Brauker, Victoria Carr-Brendel, Mark Tapsak, Dubravka Markovic
  • Publication number: 20050033132
    Abstract: An implantable analyte-measuring device including a membrane adapted to promote vascularization and/or interfere with barrier cell layer formation. The membrane includes any combination of materials, architecture, and bioactive agents that facilitate analyte transport to provide long-term in vivo performance of the implantable analyte-measuring device.
    Type: Application
    Filed: May 14, 2004
    Publication date: February 10, 2005
    Inventors: Mark Shults, James Brauker, Victoria Carr-Brendel, Mark Tapsak, Dubravka Markovic, Stuart Updike, Rathbun Rhodes